MyFinsight
Home
About
Contact
Back
Income Statement
NRX Pharmaceuticals, Inc. (NRXP)
source: myfinsight.com
Download
Download image
Net loss
-$17,581K
Total other expenses,
net
-$13,851K
Loss from operations
-$3,730K
Interest income
$2K
Change in fair value of
convertible note payable
$5,565K
Loss on convertible
note conversions
-$1,874K
Change in fair value of
warrant liabilities
$6,414K
Total operating
expenses
$3,730K
General and
administrative
$2,743K
Research and development
$987K
Back